Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
Pomalidomide is active in the treatment of anemia associated with myelofibrosis. J Clin Oncol. 2009 Sep 20; 27(27):4563-9.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Anemia
Double-Blind Method
Female
Glucocorticoids
Hematinics
Humans
Immunologic Factors
Male
Middle Aged
Prednisone
Primary Myelofibrosis
Prospective Studies
Thalidomide
authors with profiles
James W. Vardiman